TIDMCHRY
RNS Number : 3580V
Chrysalis Investments Limited
13 December 2021
The information contained in this announcement is restricted and
is not for publication, release or distribution in the United
States of America, any member state of the European Economic Area
(other than to professional investors in Belgium, Denmark, the
Republic of Ireland, Luxembourg, the Netherlands, Norway and
Sweden), Canada, Australia, Japan or the Republic of South
Africa.
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014 as amended by The
Market Abuse (Amendment) (EU Exit) Regulations 2019.
13 December 2021
Chrysalis Investments Limited
("Chrysalis" or the "Company")
Result of Capital Raise
Further to the Company's announcements on 1 December 2021,
Chrysalis Investments Limited announces that it has raised gross
proceeds of GBP60 million pursuant to the Placing and the
PrimaryBid Offer (the "Issue"). Accordingly, under the Issue an
aggregate of 25,210,084 new Ordinary Shares have been issued and
allotted conditionally upon admission at a price of 238 pence per
Ordinary Share.
The Company is pleased to have had positive engagement with a
range of investors throughout the placing and is grateful for the
continued support of its shareholders, particularly in what has
become a more challenging market environment, in light of recent
developments regarding the Omicron variant of Covid-19.
The Investment Adviser expects to deploy the proceeds of the
Issue primarily to drive the performance of existing portfolio
companies via certain follow-on investments.
Application for Admission
Application has been made for 25,210,084 million New Ordinary
Shares to be admitted to the premium segment of the Official List
of the FCA and to trading on the Main Market of the London Stock
Exchange. It is expected that admission in respect of the New
Ordinary Shares will become effective, and that dealings in the New
Ordinary Shares will commence, at 8.00 a.m. on 15 December
2021.
Total Voting Rights
Following the Placing and PrimaryBid Offer, Chrysalis' issued
share capital will consist of 572,483,160 Ordinary Shares with
voting rights in the Company. This figure may be used by
Shareholders in determining the denominator for the calculation by
which they will establish if they are required to notify their
interest in, or a change to their interest in, the Company under
the FCA's Disclosure Guidance and Transparency Rules.
Liberum Capital Limited and Numis Securities Limited acted as
Joint Bookrunners in respect of the Placing.
Capitalised terms shall have the meanings attributed to them in
the Prospectus unless otherwise defined in this announcement.
For further information please contact:
Maitland Administration (Guernsey)
Limited
Elaine Smeja +44 (0) 1481 749364
Jupiter Asset Management
Magnus Spence +44 (0) 20 3817 1325
Liberum Capital Limited
Chris Clarke / Darren Vickers /
Owen Matthews
Numis Securities Limited +44 (0) 20 3100 2000
Nathan Brown / Matt Goss +44 (0) 20 7260 1000
IMPORTANT INFORMATION
This announcement has been issued by and is the sole
responsibility of the Company. Liberum Capital Limited ("Liberum")
and Numis Securities Limited ("Numis" and together with Liberum,
the "Joint Bookrunners"), each of which are authorised and
regulated by the Financial Conduct Authority in the United Kingdom,
are acting only for the Company in connection with the matters
described in this announcement and are not acting for or advising
any other person, or treating any other person as its client, in
relation thereto and will not be responsible for providing the
regulatory protection afforded to clients of each of them or advice
to any other person in relation to the matters contained herein.
Neither Liberum, Numis nor any of its or their respective
affiliates, directors, officers, employees, advisers or agents
accepts any responsibility or liability whatsoever for this
announcement, its contents or otherwise in connection with it or
any other information relating to the Company, whether written,
oral or in a visual or electronic format.
The Joint Bookrunners have not authorised the contents of, or
any part of, this announcement and no liability whatsoever is
accepted by the Joint Bookrunners for the accuracy of any
information or opinions contained in this announcement or for the
omission of any information. No representation or warranty, express
or implied, is made by the Joint Bookrunners as to the accuracy,
completeness or verification of the information set out in this
announcement, and nothing contained in this announcement is, or
shall be relied upon as, a promise or representation in this
respect, whether as to the past or the future. The Joint
Bookrunners do not assume any responsibility for its accuracy,
completeness or verification and accordingly disclaims, to the
fullest extent permitted by applicable law, any and all liability
whether arising in tort, contract or otherwise which it might
otherwise be found to have in respect of this announcement or any
such statement.
This announcement does not constitute or form part of any offer
or invitation to sell or issue, or any solicitation of any offer to
purchase or subscribe for, any Ordinary Shares (i) in any
jurisdiction in which such offer, invitation or solicitation is not
authorised; (ii) in any jurisdiction in which the person making
such offer, invitation or solicitation is not qualified to do so;
or (iii) to any person to whom it is unlawful to make such offer,
invitation or solicitation. The distribution of this announcement
and the offer of the Ordinary Shares may be restricted by law.
Persons into whose possession this announcement comes must
therefore inform themselves about and observe any such
restrictions. Any failure to comply with these restrictions may
constitute a violation of the securities laws of any such
jurisdiction. In particular, this announcement may not be
distributed, forwarded to or transmitted in, into or from the
United States, Australia, Canada, Japan, South Africa, or any
member state of the EEA or to any US person (as defined under
Regulation S of the US Securities Act of 1933, as amended (the "US
Securities Act")) ("US Person"). The Ordinary Shares have not been,
and will not be, registered under the US Securities Act, or under
any securities laws of any state or other jurisdiction of the
United States and may not be offered, sold, resold, transferred or
delivered, directly or indirectly, in or into the United States or
to, or for the account or benefit of, any US Person, except
pursuant to an applicable exemption from the registration
requirements of the US Securities Act and in compliance with the
securities laws of any state or other jurisdiction of the United
States. Any person within the United States and any US person who
obtains a copy of this announcement must disregard it. No public
offering of the Ordinary Shares is being made in any jurisdiction.
No action has been or will be taken by the Company or the Joint
Bookrunners that would permit the offer of the Ordinary Shares or
possession or distribution of this announcement in any jurisdiction
where action for that purpose is required.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROIDKBBKKBDBBBD
(END) Dow Jones Newswires
December 13, 2021 02:00 ET (07:00 GMT)
Merian Chrysalis Investm... (LSE:MERI)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Merian Chrysalis Investm... (LSE:MERI)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024